NewEdge Wealth LLC Sells 36,653 Shares of BlackRock Science and Technology Term Trust $BSTZ

NewEdge Wealth LLC trimmed its holdings in shares of BlackRock Science and Technology Term Trust (NASDAQ:BSTZ) by 68.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,816 shares of the company’s stock after selling 36,653 shares during the quarter. NewEdge Wealth LLC’s holdings in BlackRock Science and Technology Term Trust were worth $386,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Amplius Wealth Advisors LLC raised its stake in shares of BlackRock Science and Technology Term Trust by 2.8% in the third quarter. Amplius Wealth Advisors LLC now owns 17,990 shares of the company’s stock valued at $399,000 after acquiring an additional 494 shares during the period. Stablepoint Partners LLC grew its holdings in BlackRock Science and Technology Term Trust by 4.6% during the 2nd quarter. Stablepoint Partners LLC now owns 11,270 shares of the company’s stock valued at $234,000 after purchasing an additional 500 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in BlackRock Science and Technology Term Trust by 13.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 6,638 shares of the company’s stock worth $138,000 after purchasing an additional 767 shares during the period. Merit Financial Group LLC raised its position in BlackRock Science and Technology Term Trust by 7.6% in the 3rd quarter. Merit Financial Group LLC now owns 11,938 shares of the company’s stock worth $265,000 after purchasing an additional 847 shares during the period. Finally, HBK Investments L P boosted its position in shares of BlackRock Science and Technology Term Trust by 2.2% during the second quarter. HBK Investments L P now owns 52,222 shares of the company’s stock valued at $1,084,000 after buying an additional 1,103 shares during the period.

BlackRock Science and Technology Term Trust Stock Up 0.0%

BSTZ opened at $22.95 on Wednesday. The stock’s 50 day moving average price is $22.77 and its 200-day moving average price is $22.33. BlackRock Science and Technology Term Trust has a one year low of $15.22 and a one year high of $23.47.

BlackRock Science and Technology Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be paid a $0.1625 dividend. The ex-dividend date is Friday, March 13th. This represents a c) dividend on an annualized basis and a yield of 8.5%.

Insider Buying and Selling at BlackRock Science and Technology Term Trust

In related news, Director Robert W. Fairbairn sold 9,293 shares of BlackRock Science and Technology Term Trust stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $22.51, for a total transaction of $209,185.43. Following the completion of the sale, the director owned 1 shares in the company, valued at $22.51. This trade represents a 99.99% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Portfolio Manager Tony Kim acquired 41,825 shares of the stock in a transaction on Thursday, February 5th. The stock was bought at an average cost of $22.00 per share, with a total value of $920,150.00. Following the completion of the transaction, the portfolio manager owned 251,554 shares in the company, valued at $5,534,188. This trade represents a 19.94% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing.

BlackRock Science and Technology Term Trust Company Profile

BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.

The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.